Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Axim Biotech Enters Canada Through Partnership With Revive Therapeutics

Axim Biotech Enters Canada Through Partnership With Revive TherapeuticsNew York-based AXIM Biotechnologies (OTC: AXIM), a cannabinoid R&D firm focusing on delivery systems, announced in late August it signed an exclusive distribution and license agreement with Revive Therapeutics Ltd. (TSX: RVV) (OTC: RVVTF), a specialty cannabis R&D company, to begin selling AXIM’S proprietary, CBD-containing nutraceutical product throughout Canada.

According to Deloitte, the legal cannabis industry in Canada could surge by 58% and generate over $4 billion in sales in its first year. 

Revive will seek regulatory approval for AXIM’s proprietary, controlled-release chewing gum containing hemp oil-derived CBD. Revive will also have a minimum purchase amount annually, which increases each year for the term of the agreement.

“We…hope this will create a new revenue stream for both companies and fill a void in quality, tested and proven CBD products for consumers there,” said George E. Anastassov, CEO of AXIM.

In its natural form, cannabinoids are lipophilic, not water-soluble and tend to stick to the chewing gum matrix, diminishing effective release. Microencapsulation makes cannabinoids soluble and increases the bioavailability of CBD.

AXIM’s flagship products include MedChew Rx®, a combination CBD/THC gum that will undergo clinical trials for the treatment of multiple sclerosis; MedChew® Dronabinol which will undergo a bioequivalence study to fast track through FDA as an alternative to approved Marinol; and CanChew RL, which will undergo clinical trials for treatment of restless leg syndrome.

Revive Therapeutics Ltd. (TSX:RVV) (OTC:RVVTF) is a specialty cannabis company focused on the R&D and commercialization of novel cannabinoid-based products and therapies.  

Source Axim press release

Axim Biotech Enters Canada Through Partnership With Revive Therapeutics

About Cannin: Your Cannabis Stocks Resource

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020. 

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012


We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.


Profit from the best cannabis stocks – we’ll show you how at

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp stocks